Risedronate sodium 30mg tablets
BNF presentation 0606020R0AAABAB within chapter Endocrine System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0606020R0AAABAB
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
173
NHS spend (£)
£15,677.25
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 12 |
| February 2025 | 1 |
| December 2024 | 8 |
| November 2024 | 29 |
| October 2024 | 17 |
| July 2024 | 31 |
| May 2024 | 4 |
| July 2021 | 15 |
| June 2021 | 9 |
| December 2020 | 19 |
| November 2020 | 28 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 25 | No data available |
| Unknown pharmacy | 15 | No data available |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |